Click here to answer our weekly poll.
Dermatology Times Staff
Advertisement
Articles by Dermatology Times Staff
A glimpse at what to expect from Dermatology Times this week.
Topical retapamulin was effective in clearing impetigo lesions according to a presentation given at the recent Maui Derm conference.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
MJH Life Sciences COVID-19 Coalition webinar on Jan. 26 will focus on COVID-19 variants emerging around the globe.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
A glimpse at what to expect from Dermatology Times this week.
A glimpse at what to expect from Dermatology Times this week.
A glimpse at what to expect from Dermatology Times this week.
A glimpse at what to expect from Dermatology Times this week.
A glimpse at what to expect from Dermatology Times this week.
A glimpse at what to expect from Dermatology Times this week.
A glimpse at what to expect from Dermatology Times this week.
Studies confirm improvement achieved and maintained through one year of active treatment with similar scores for patients switching from placebo to guselkumab.
A glimpse at what to expect from Dermatology Times this week.
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
Chronic Hand Eczema: Treatment Gaps, New Options, and Clinical Trial End Points
2
David Rosmarin, MD, on CHE Heterogeneity and Unmet Needs in AD and Vitiligo
3
Mona Shahriari, MD, FAAD: Matching the Right AD Therapy to the Right Patient
4
Clinique's Daily Calm Merges Clinical Efficacy with Color Cosmetics for Sensitive Skin
5